stars 1 stars 2 stars 3

In 2023 Biocatalysts Ltd successfully completed the acquisition of Breatec, WeissBioTech and Biosun from its parent company BRAIN Biotech AG, creating the Bioproducts division under the Biocatalysts brand. Biocatalysts Ltd is an industry expert in the discovery, development, and manufacture of multi-speciality enzymes. As Biocatalysts Beverages & Grain Processing, formerly known as WeissBioTech, we offer an exceptional and adaptable building block system of enzyme formulations, crafted to elevate your beverage creations. Our NATUZYM®, DELTAZYM® and DELTABREW® enzymes coupled with our profound application expertise empower you to unlock the full potential of fruit & vegetable processing, winemaking and carbohydrate-based applications such as malts and beer or potable alcohol and bioethanol. Our operations in Germany are certified under the ISO 9001 and FSSC 22000 food safety management quality systems and audited accordingly on a yearly basis. We are a full member of AMFEP, the Association of Manufacturers and Formulators of Enzyme Products.

WeissBioTech Questions

The WeissBioTech annual revenue was $5 million in 2026.

Matthias Enste is the Managing Director of WeissBioTech.

5 people are employed at WeissBioTech.

WeissBioTech is based in Ascheberg, Nordrhein-Westfalen.

The NAICS codes for WeissBioTech are [541713, 541, 54171, 5417, 54].

The SIC codes for WeissBioTech are [873, 87].

Top WeissBioTech Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users